NYSE:NUS - New York Stock Exchange, Inc. - US67018T1051 - Common Stock - Currency: USD
Shares of personal care company Nu Skin (NYSE:NUS) jumped 13.3% in the morning session after the company reported strong preliminary Q4 2024 guidance, with revenue expected to be at the high end of the previous guidance range. A day after this report, the company is expected to share updates on its strategy, including the recent sale of Mavely for $250 million. Overall, the updates provide more reasons for investors to stay optimistic.
Shares of personal care company Nu Skin (NYSE:NUS) jumped 21.9% in the morning session after the company announced the sale of the Mavely affiliate technology platform, owned by its subsidiary Rhyz Inc., to Later, a marketing and social media management software firm. Valued at $250 million, the deal delivered a substantial payoff, with management adding, "This transaction yielded roughly a fivefold return on the company's total investment in Mavely since its acquisition in 2021."
Nu Skin Enterprises, Inc. (NYSE:NUS) saw its shares rise on Friday following the announcement of a strategic transaction by its Rhyz Inc. subsidiary. Rhyz has sold its Mavely affiliate marketing technology platform to Later, a portfolio company of Summit Partners, for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. The deal, which also includes $33 million to be paid to other equity holders in the Mavely business, is part of Nu Skin’s broader
Nu Skin's stock rose premarket on Friday following the announcement of its Rhyz subsidiary selling the Mavely platform to Later for $250 million.
/PRNewswire/ -- Later, a leader in influencer marketing and social media management software and services, today announced its acquisition of Mavely, the...
/PRNewswire/ -- More than a quarter (28%) of consumers have purchased a gift based on a recommendation from a creator or influencer in the past year, according...
/PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior...
/PRNewswire/ -- Mavely, the Everyday Influencer Platform®, today announces remarkable achievements, underscoring its position as a rapidly growing player in...
Discover the top three stocks to sell that are on the list and the critical weaknesses affecting their stock performance.
The company's guidance for its current quarter fell short of expectations.
NUS stock results show that Nu Skin Enterprises beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.